Close
Smartlab Europe
Achema middle east

News

New Drug Mix From ICR And The Royal Marsden Shows Promise

The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein have been released by the Institute of Cancer Research (ICR) in London and The Royal Marsden NHS Foundation Trust. In...

Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners

Thermo Fisher Scientific, the world leader in serving science, announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its eighth year, the research competition selects scientists from a pool of international applicants...

Thermo Fisher Scientific Collaborates with TransMIT GmbH on a High-Performance Orbitrap Mass Spectrometry Imaging Platform

Thermo Fisher Scientific Inc., the world leader in serving science, and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in...

ICMR Gives Guidelines For Drones To Deliver Medical Supplies

The Indian Council of Medical Research, the country's apex agency for biomedical research, has issued guidelines for the use of drones in health. WHAT IS IT USED FOR? The 28-page guide provides step-by-step instructions for gaining regulatory licences for deploying various...

Novartis Victim of Cyberattack But No Sensitive Data Leaked

Cyberattacks affect everyone, including pharmaceutical behemoths like Novartis. The week ending June 4th, specialised IT website Bleeping Computer revealed that Industrial Spy, a hacker gang that operates an extortion marketplace trading stolen information, posted data supposedly taken from Novartis. Fortunately...

Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production

COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take, for example, Pfizer's new $120 million investment. The company announced on June 6 that it will use the funds to expand manufacturing of its oral...

USFDA Cautions of Heart Issues Post Novavax COVID Vaccine

Even though the company's analysis found it could reduce the likelihood of mild-to-severe disease, the US Food and Drug Administration has expressed concern about a potential hazard of heart inflammation from Novavax Inc's COVID-19 vaccine. Within 20 days of receiving...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »